Status:
UNKNOWN
Preeclampsia Sequential Screening Using Angiogenic Factors During First Trimester of Pregnancy
Lead Sponsor:
Instituto de Investigación Sanitaria Aragón
Collaborating Sponsors:
Instituto de Salud Carlos III
Conditions:
Pre-Eclampsia
Pregnancy Complications
Eligibility:
FEMALE
18+ years
Brief Summary
Preeclampsia (PE) affects from 2 to 8% of pregnant women. Recent studies show that prevention is the best strategy to improve perinatal outcomes. Therefore, the development of new strategies for preec...
Detailed Description
All the data required to carry out this study, including those derived from sonographies and blood tests, will be collected during the normal pregnancy control, without further appointments. A blood t...
Eligibility Criteria
Inclusion
- Singleton pregnancies;
- Gestational age less than 14 weeks, estimated according to Crown-Rump Length (CRL);
- Blood sample between 8 and 14 weeks of pregnancy;
- Patients who accept to participate in the study and sign the informed consent
Exclusion
- Fetus with chromosomal disorders, major congenital malformations or congenital infections diagnosed in the first-trimester ultrasound;
- Multiple pregnancies;
- Non-acceptance of participation in the study.
Key Trial Info
Start Date :
March 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2022
Estimated Enrollment :
6560 Patients enrolled
Trial Details
Trial ID
NCT04767438
Start Date
March 1 2021
End Date
September 1 2022
Last Update
February 23 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.